Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van der Flier

Showing results (211-220 of 791) with videos related to

Pageof 80
Sort By:
Alzheimer'S Research & Therapy|January 8, 2021
Biomarker testing in MCI patients-deciding who to testIngrid S van Maurik, Hanneke F M Rhodius-Meester, Charlotte E Teunissen, et al.
Journal of the American Heart Association|February 14, 2024
Plasma Markers of Alzheimer's Disease Pathology, Neuronal Injury, and Astrocytic Activation and MRI Load of Vascular Pathology and Neurodegeneration: The SMART-MR StudyEmma L Twait, Lotte Gerritsen, Justine E F Moonen, et al.
Patient Education and Counseling|December 7, 2024
The need for personalization when sharing results of amyloid imaging for Alzheimer's disease: Insights from a randomized experimental studyAgnetha D Fruijtier, Wiesje M van der Flier, Ingrid van Maurik, et al.
The Lancet. Neurology|November 28, 2021
Blood-based biomarkers for Alzheimer's disease: towards clinical implementationCharlotte E Teunissen, Inge M W Verberk, Elisabeth H Thijssen, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2010
Additional value of CSF amyloid-beta 40 levels in the differentiation between FTLD and control subjectsNicolaas A Verwey, Maartje I Kester, Wiesje M van der Flier, et al.
Congestive Heart Failure (Greenwich, Conn.)|April 11, 2008
Transcranial Doppler blood flow assessment in patients with mild heart failure: correlates with neuroimaging and cognitive performanceRaymond L C Vogels, Joukje M Oosterman, David M Laman, et al.
Neuroimage. Clinical|April 23, 2025
Individualized lesion-symptom mapping using explainable artificial intelligence for the cognitive impact of white matter hyperintensitiesRyanne Offenberg, Alberto De Luca, Geert Jan Biessels, et al.
Journal of Alzheimer'S Disease : JAD|March 21, 2025
Exploring interdisciplinary perspectives on the implementation of <i>personalized medicine</i> and <i>patient-orchestrated care</i> in Alzheimer's disease: A qualitative study within the ABOARD research projectTanja J de Rijke, Dianne Vasseur, Wiesje M van der Flier, et al.
Neurology|March 10, 2019
Clinical relevance of acute cerebral microinfarcts in vascular cognitive impairmentDoeschka A Ferro, Hilde van den Brink, Lieza G Exalto, et al.
Journal of the International Neuropsychological Society : JINS|December 31, 2011
Improving the accuracy and precision of cognitive testing in mild dementiaHans Wouters, Bregje Appels, Wiesje M van der Flier, et al.
Pageof 80

Showing results (211-220 of 791) with videos related to

Sort By:
Pageof 80
Alzheimer'S Research & Therapy|January 8, 2021
Biomarker testing in MCI patients-deciding who to testIngrid S van Maurik, Hanneke F M Rhodius-Meester, Charlotte E Teunissen, et al.
Journal of the American Heart Association|February 14, 2024
Plasma Markers of Alzheimer's Disease Pathology, Neuronal Injury, and Astrocytic Activation and MRI Load of Vascular Pathology and Neurodegeneration: The SMART-MR StudyEmma L Twait, Lotte Gerritsen, Justine E F Moonen, et al.
Patient Education and Counseling|December 7, 2024
The need for personalization when sharing results of amyloid imaging for Alzheimer's disease: Insights from a randomized experimental studyAgnetha D Fruijtier, Wiesje M van der Flier, Ingrid van Maurik, et al.
The Lancet. Neurology|November 28, 2021
Blood-based biomarkers for Alzheimer's disease: towards clinical implementationCharlotte E Teunissen, Inge M W Verberk, Elisabeth H Thijssen, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2010
Additional value of CSF amyloid-beta 40 levels in the differentiation between FTLD and control subjectsNicolaas A Verwey, Maartje I Kester, Wiesje M van der Flier, et al.
Congestive Heart Failure (Greenwich, Conn.)|April 11, 2008
Transcranial Doppler blood flow assessment in patients with mild heart failure: correlates with neuroimaging and cognitive performanceRaymond L C Vogels, Joukje M Oosterman, David M Laman, et al.
Neuroimage. Clinical|April 23, 2025
Individualized lesion-symptom mapping using explainable artificial intelligence for the cognitive impact of white matter hyperintensitiesRyanne Offenberg, Alberto De Luca, Geert Jan Biessels, et al.
Journal of Alzheimer'S Disease : JAD|March 21, 2025
Exploring interdisciplinary perspectives on the implementation of <i>personalized medicine</i> and <i>patient-orchestrated care</i> in Alzheimer's disease: A qualitative study within the ABOARD research projectTanja J de Rijke, Dianne Vasseur, Wiesje M van der Flier, et al.
Neurology|March 10, 2019
Clinical relevance of acute cerebral microinfarcts in vascular cognitive impairmentDoeschka A Ferro, Hilde van den Brink, Lieza G Exalto, et al.
Journal of the International Neuropsychological Society : JINS|December 31, 2011
Improving the accuracy and precision of cognitive testing in mild dementiaHans Wouters, Bregje Appels, Wiesje M van der Flier, et al.
Pageof 80